JOHNSON & JOHNSON (JNJ)

A forensic read on JOHNSON & JOHNSON built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

Johnson & Johnson is a global healthcare company focused on human health and well-being, operating primarily through its Innovative Medicine (pharmaceuticals) and MedTech segments, driven by a broad portfolio of prescription medicines and medical devices. The company's revenue GREW from $76.45B (FY2017) to $94.19B (FY2025), while its net margin expanded from 1.7% (FY2017) to 28.5% (FY2025).

← Browse all forensic stock analyses

Data from SEC EDGAR public filings. Forensic signals flag probability, not certainty.